The Sydney Cricket Ground and the Australian team caps were adorned in pink ahead of the fifth and final Test against India. The change in colour from the Baggy Green to the Baggy Pink marks the ...

Because cystic fibrosis affects multiple organ systems, including the lungs and digestive system, people with the condition often need care from a team of healthcare professionals. Cystic fibrosis ...

China has achieved a breakthrough in satellite-to-ground laser communications that could pave the way for 6G and other applications including remote sensing with ultra-high resolution and next ...

The latest figures from the Department for Work and Pensions (DWP) show that there were 7.2 million people across Scotland, England and Wales, receiving financial support through Universal Credit ...

GREENVILLE, S.C. (FOX Carolina) - As the new year approaches, the city of Greenville expects to break ground in 2025 on a project that could change the face of downtown. For decades, developers ...

This collection of 22 shorts by Palestinian filmmakers presents on-the-ground accounts of life and death that might otherwise be ignored. By Nicolas Rapold When you purchase a ticket for an ...

CMTX-101 is under clinical development by Clarametyx Biosciences and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase II drugs for Cystic Fibrosis have a 31% phase transition ...

The Federal Aviation Administration (FAA) announced a ground stop for all American Airlines flights on Christmas Eve morning. The directive came as the airline experienced a technical issue that ...

American Airlines flights were briefly grounded Tuesday morning due to a technical issue, but the Federal Aviation Administration (FAA) said the ground stop was lifted by about 8 a.m. EST.

Gunnar Esiason isn't like most hockey players -- his ability to complete a shift often depended on how his cystic fibrosis was affecting ... the dad banging on the glass while I was out there ...

As Vertex Pharmaceuticals reels from a painful trial readout for its pain candidate suzetrigine, the Boston biotech has chalked up a win in its specialty area of cystic fibrosis. The FDA has ...